Page last updated: 2024-12-08
1-methyl-2-nitrosoimidazole
## 1-Methyl-2-nitrosoimidazole: A Versatile Research Tool
**1-Methyl-2-nitrosoimidazole (MNI)** is a small organic molecule with a unique chemical structure containing both a nitroso group (-NO) and an imidazole ring. It is not a naturally occurring compound but rather a synthetic chemical used primarily in research.
**Key properties of MNI:**
* **Reactive electrophile:** The nitroso group makes MNI a potent electrophile, readily reacting with nucleophilic groups on other molecules.
* **Stable in solid form:** MNI is relatively stable in solid form, allowing for easy storage and handling.
* **Water-soluble:** This property facilitates its use in various biological systems.
* **Versatile reactivity:** MNI can react with a wide range of molecules, including thiols, amines, and even DNA.
**Why is MNI important for research?**
MNI has been employed in several research areas due to its versatility and reactivity:
* **Nitric oxide (NO) research:** MNI is a well-established NO scavenger, acting as a valuable tool to study the role of NO in various biological processes. It can be used to monitor NO levels or to block NO-dependent signaling pathways.
* **Chemical biology and drug discovery:** MNI's reactivity with biomolecules has led to its use in chemical biology studies. It can be used to probe protein function, identify active sites, and develop novel drugs.
* **Bioimaging:** MNI can be used to create fluorescent probes for imaging biological processes. Its reaction with biomolecules can lead to changes in fluorescence properties, allowing researchers to visualize specific cellular events.
* **Materials science:** MNI's reactivity with various materials has led to its exploration as a potential building block for novel materials.
**Research areas where MNI is used:**
* **Neuroscience:** Understanding the role of NO in neuronal function and neurotoxicity.
* **Cancer research:** Investigating the role of NO in cancer progression and exploring MNI as a potential anti-cancer agent.
* **Cardiovascular research:** Studying the role of NO in regulating blood pressure and cardiovascular function.
* **Immunology:** Investigating the role of NO in immune responses and inflammation.
**Overall, 1-methyl-2-nitrosoimidazole is a valuable research tool used to study a wide range of biological processes. Its unique properties make it a potent reagent for probing biomolecular interactions, developing new therapeutic agents, and exploring novel materials.**
It's important to note that MNI is a potentially toxic compound and should be handled with appropriate safety precautions.
Cross-References
ID Source | ID |
PubMed CID | 146582 |
SCHEMBL ID | 3685152 |
MeSH ID | M0158440 |
Synonyms (12)
Synonym |
ccris 1310 |
1-methyl-2-nitrosoimidazole |
1h-imidazole, 1-methyl-2-nitroso- |
1-mni |
AKOS006278737 |
116169-87-0 |
unii-fn48115pku |
fn48115pku , |
SCHEMBL3685152 |
DTXSID60151305 |
1-methyl-2-nitroso-1h-imidazole |
Q27894323 |
Research Excerpts
Toxicity
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.67
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.67 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 4.62 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |